Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

NGM Biopharmaceuticals Inc (NGM)

NASDAQ
Currency in USD
Disclaimer
1.54
0.00(0.00%)
Closed

NGM Comments

ready to fly, maybe some small shake out tomorrow, then only UP
this going back to $20 or no?
if you know something please let me know. Do you have any opinion about MYOVANT ?
Dear Henry do you know something please too ?
hello Henry ? this is Szilike, do you know any about therapeutic drug testing please ? if yes give me more details. I entried to NGM before few days at 15.39usd and I sold at 16.12usd was good earnings. is still worths to entry . their 10% owner bought 1st week of April some millions of usdollars in shares at 14.95usd. do you know that ? please let's help each other to exchange informations . i will appreciate so much .
I looked them up as a company and they seem to have some therapeutics that are in trials or in line for approval. Not sure exactly the status cuz I’m not an insider and thats not public info. I’ll let you know if i find out more. Technicals and financials looks good though so its still on the up and up right now
any news for NGM please Mr. Rivera ?
it was nice call to buy price collapsed many times since then!!? NOW ITS TIME TO BUY!!!
Any news on the approval of the therapeutic drug testing?
hello anybody here to speak about NGM ?
hello anybody here ? NGM will rise up to 31usd ?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.